BFSG LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-209
Closed -$15.8K 722
2025
Q3
$15.8K Buy
+209
New +$14.3K ﹤0.01% 500
2023
Q3
Sell
-19,223
Closed -$1.33M 255
2023
Q2
$1.33M Sell
19,223
-12,083
-39% -$860K 0.23% 110
2023
Q1
$2.33M Buy
31,306
+50
+0.2% +$4.19K 0.43% 84
2022
Q4
$2.91M Buy
31,256
+374
+1% +$36.1K 0.58% 65
2022
Q3
$2.94M Sell
30,882
-440
-1% -$43.6K 0.63% 61
2022
Q2
$2.9M Buy
31,322
+2,788
+10% +$272K 0.52% 71
2022
Q1
$2.89M Sell
28,534
-1,605
-5% -$169K 0.46% 68
2021
Q4
$3.11M Buy
30,139
+272
+0.9% +$25.1K 0.43% 75
2021
Q3
$2.54M Buy
29,867
+560
+2% +$46.9K 0.39% 82
2021
Q2
$2.44M Buy
29,307
+480
+2% +$39.3K 0.44% 81
2021
Q1
$2.17M Sell
28,827
-311
-1% -$22.7K 0.35% 91
2020
Q4
$1.99M Sell
29,138
-85,060
-74% -$5.53M 0.33% 89
2020
Q3
$6.67M Buy
+114,198
New +$7.11M 1.24% 26
2020
Q2
Sell
-30,897
Closed -$1.83M 168
2020
Q1
$1.83M Sell
30,897
-610
-2% -$40.7K 0.47% 69
2019
Q4
$2.34M Sell
31,507
-885
-3% -$62.1K 0.44% 73
2019
Q3
$1.99M Buy
+32,392
New +$1.92M 0.44% 69

Other funds holding CVS

BFSG LLC's CVS Position: Q4 2025 in Review

BFSG LLC sold out of CVS Health (CVS) in Q4 2025, closing a stake of 209 shares — an estimated $15.8K sold.

BFSG LLC first reported a position in CVS in Q3 2019 and held it in 16 quarters. The position peaked at $6.67M in Q3 2020. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • BFSG LLC reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • BFSG LLC sold 209 CVS Health shares in Q4 2025, an estimated $15.8K.
  • BFSG LLC first reported a position in CVS Health in Q3 2019 and held it in 16 quarters.
  • BFSG LLC's CVS Health position peaked at $6.67M in Q3 2020.
  • 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on BFSG LLC's 13F filing for Q4 2025, filed 22 Jan 2026.